Correlation Between Stoke Therapeutics and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Mereo BioPharma Group, you can compare the effects of market volatilities on Stoke Therapeutics and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Mereo BioPharma.
Diversification Opportunities for Stoke Therapeutics and Mereo BioPharma
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Stoke and Mereo is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Mereo BioPharma go up and down completely randomly.
Pair Corralation between Stoke Therapeutics and Mereo BioPharma
Given the investment horizon of 90 days Stoke Therapeutics is expected to generate 0.92 times more return on investment than Mereo BioPharma. However, Stoke Therapeutics is 1.09 times less risky than Mereo BioPharma. It trades about -0.04 of its potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.24 per unit of risk. If you would invest 1,231 in Stoke Therapeutics on August 28, 2024 and sell it today you would lose (53.00) from holding Stoke Therapeutics or give up 4.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Stoke Therapeutics vs. Mereo BioPharma Group
Performance |
| Timeline |
| Stoke Therapeutics |
| Mereo BioPharma Group |
Stoke Therapeutics and Mereo BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stoke Therapeutics and Mereo BioPharma
The main advantage of trading using opposite Stoke Therapeutics and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.| Stoke Therapeutics vs. Adaptimmune Therapeutics Plc | Stoke Therapeutics vs. Black Diamond Therapeutics | Stoke Therapeutics vs. Relay Therapeutics | Stoke Therapeutics vs. Pliant Therapeutics |
| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |